Have a personal or library account? Click to login
Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation Cover

Mixed-field ABO front typing as an early sign of disease recurrence in ABO-matched stem cell transplantation

Immunohematology
Volume 40 (2024): Issue 3 (September 2024)
By: Nalan Yurtsever,  Edward S. Lee,  Lisa Pinatti,  Bhushan Shah,  Christopher A. Tormey and  Alexa J. Siddon  
Open Access
|Oct 2024

References

  1. Blouin AG, Askar M. Chimerism analysis for clinicians: a review of the literature and worldwide practices. Bone Marrow Transplant 2022;57:347–59. doi: 10.1038/s41409-022-01579-9.
    Search in Google ScholarBack to article
  2. Meny GM. Recognizing and resolving ABO discrepancies. Immunohematology 2017;33:76–81.
    Search in Google ScholarBack to article
  3. Qiu H, Wang X, Shao Y. Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment. Hematology 2023; 28:2240146. doi: 10.1080/16078454.2023.2240146.
    Search in Google ScholarBack to article
  4. Jeong IH, Seo JY, Choi S, Kim HY, Cho D. ABO blood group antigen changes in acute myeloid leukemia and no significant association with RUNX1 and GATA2 somatic variants. Ann Lab Med 2023;43:635–7. doi: 10.3343/alm.2023.43.6.635.
    Search in Google ScholarBack to article
  5. Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood 2001;97:3633–9. doi: 10.1182/blood.v97.11.3633.
    Search in Google ScholarBack to article
  6. Fathima S, Killeen RB. ABO typing discrepancies. Treasure Island, FL: StatPearls Publishing. Updated 17 December 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK585061/. Accessed 6 March 2024.
    Search in Google ScholarBack to article
  7. Chenna D, Mohan G, Reddy VR, Shastry S. The disappearance of blood group antigens: a clue to the clinical diagnosis of leukemia. Transfus Apher Sci 2019;58:48–9. doi: 10.1016/j. transci.2018.11.010.
    Search in Google ScholarBack to article
  8. Sarma R, Kuli K, Kalita C, Iqbal A, Gupta S. Loss of blood group antigens in haematolymphoid malignancy: a case series from a cancer institute from North East India. Asian Pacific J Cancer Care 2024;9:165–8. doi: 10.31557/APJCC.2024.9.1.165.
    Search in Google ScholarBack to article
  9. Elzein HO. Association of leukemia with ABO blood group distribution and discrepancy: a review article. Cureus 2024; 16:e56812. doi: 10.7759/cureus.56812.
    Search in Google ScholarBack to article
  10. Ting SC, Sainamthip P, Hsiao HH, Liu TC. Discrepancy of ABO typing in acute leukemia patients. Kaohsiung J Med Sci 2016;32:595–6. doi: 10.1016/j.kjms.2016.06.004.
    Search in Google ScholarBack to article
  11. Nambiar RK, Narayanan G, Prakash NP, Vijayalakshmi K. Blood group change in acute myeloid leukemia. Proc Bayl Univ Med Cent 2017;30:74–5. doi: 10.1080/08998280.2017.11929536.
    Search in Google ScholarBack to article
  12. Desai P, Naukudkar A, Rajadhyaksha S. ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: analysis and serological resolution. Hematol Transfus Cell Ther 2023;S2531-1379(23)00168-2. doi: 10.1016/j.htct.2023.07.011.
    Search in Google ScholarBack to article
  13. Mishra D, Ray GK, Mahapatra S, Parida P. ABO typing error resolution and transfusion support in a case of an acute leukemia patient showing loss of antigen expression. Cancer Transl Med 2019;5:80–2. doi: 10.4103/ctm.ctm_28_19.
    Search in Google ScholarBack to article
  14. Shafiq M, Karim F. Red cell antigen loss in a patient with chronic myeloid leukemia: a case of ABO discrepancy. Transfus Apher Sci 2015;52:103–4. doi: 10.1016/j.transci.2014.11.004.
    Search in Google ScholarBack to article
  15. Van Loghem JJ Jr, Dorfmeier H, Van Der Hart M. Two A antigens with abnormal serologic properties. Vox Sang 1957;2:16–24. doi: 10.1111/j.1423-0410.1957.tb03429.x.
    Search in Google ScholarBack to article
  16. Cho J, Hur M, Moon H, Yun Y, Lee MH, Han S-H. Loss of red cell a antigen in a patient with acute myeloid leukemia: a case report and review of the literature. Korean J Blood Transfus 2011;22:277–83.
    Search in Google ScholarBack to article
  17. Grujić J, Bujandrić N, Malenković G. Resolving blood group discrepancy in a patient with acute myeloid leukemia: a case report. Medicinski Pregled 2022;75:314–6. doi: 10.2298/MPNS2210314G.
    Search in Google ScholarBack to article
  18. Miola MP, de Oliveira TC, Guimaraes AAG, Ricci-Junior O, de Mattos LC. ABO discrepancy resolution in two patients with acute myeloid leukemia presenting the transient weak expression of A antigen. Hematol Transfus Cell Ther 2024;46:85–8. doi: 10.1016/j.htct.2022.01.015.
    Search in Google ScholarBack to article
  19. Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev 1990;4:47–55. doi: 10.1016/s0887-7963(90)70247-7.
    Search in Google ScholarBack to article
  20. Winters JL, Howard DS. Red blood cell antigen changes in malignancy: case report and review. Immunohematology 2001;17:1–9.
    Search in Google ScholarBack to article
  21. Kuhns WJ, Oliver RT, Watkins WM, Greenwell P. Leukemia-induced alterations of serum glycosyltransferase enzymes. Cancer Res 1980;40:268–75.
    Search in Google ScholarBack to article
  22. Lopez M, Bonnet-Gajdos M, Reviron M, Janvier D, Huet M, Salmon C. An acute leukaemia augured before clinical signs by blood group antigen abnormalities and low levels of A and H blood group transferase activities in erythrocytes. Br J Haematol 1986;63:535–9. doi: 10.1111/j.1365-2141.1986. tb07531.x.
    Search in Google ScholarBack to article
  23. Yoshida A, Kumazaki T, Dave V, Blank J, Dzik WH. Suppressed expression of blood group B antigen and blood group galactosyltransferase in a preleukemic subject. Blood 1985;66:990–2.
    Search in Google ScholarBack to article
  24. Bianco-Miotto T, Hussey DJ, Day TK, O’Keefe DS, Dobrovic A. DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS One 2009;4:e4788. doi: 10.1371/journal. pone.0004788.
    Search in Google ScholarBack to article
  25. Orlow I, Lacombe L, Pellicer I, et al. Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer 1998;75:819–24. doi: 10.1002/(sici)1097-0215(19980316)75:6<;819::aid-ijc1>3.0.co;2-y.
    Search in Google ScholarBack to article
  26. Gao S, Worm J, Guldberg P, et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 2004;109:230–7. doi: 10.1002/ijc.11592.
    Search in Google ScholarBack to article
  27. Chihara Y, Sugano K, Kobayashi A, et al. Loss of blood group A antigen expression in bladder cancer caused by allelic loss and/or methylation of the ABO gene. Lab Invest 2005;85:895–907. doi: 10.1038/labinvest.3700268
    Search in Google ScholarBack to article
  28. Kronstein-Wiedemann R, Nowakowska P, Milanov P, et al. Regulation of ABO blood group antigen expression by miR-331-3p and miR-1908-5p during hematopoietic stem cell differentiation. Stem Cells 2020;38:1348–62. doi: 10.1002/stem.3251.
    Search in Google ScholarBack to article
  29. Hayakawa A, Sano R, Takahashi Y, et al. RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen. Transfusion 2020;60:184–96. doi: 10.1111/trf.15628.
    Search in Google ScholarBack to article
  30. Sharpe C, Lane D, Cote J, et al. Mixed field reactions in ABO and Rh typing chimerism likely resulting from twin haematopoiesis. Blood Transfus 2014;12:608–10. doi: 10.2450/2014.0261-13.
    Search in Google ScholarBack to article
  31. Miola MP, de Araujo C, Junior OR, de Mattos LC. Mixed field resolution in ABO phenotyping in a rare case of a blood donor with hematopoietic mosaicism. Hematol Transfus Cell Ther 2022;46:306–10. doi: 10.1016/j.htct.2022.08.006.
    Search in Google ScholarBack to article
  32. Hermelin D, Zhang D, Blackall D. Resolution of an unexpected ABO typing discrepancy in a 9-month-old patient with juvenile myelomonocytic leukemia. Clin Case Rep 2020;8:2358–60. doi: 10.1002/ccr3.3101.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/immunohematology-2024-013 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 89 - 92
Published on: Oct 4, 2024
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
chimerism,
mixed field,
ABO typing,
transplant,
disease recurrence
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2024 Nalan Yurtsever, Edward S. Lee, Lisa Pinatti, Bhushan Shah, Christopher A. Tormey, Alexa J. Siddon, published by American National Red Cross
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 40 (2024): Issue 3 (September 2024)Next article